Relationships between serum and urine phosphorus with all-cause and cardiovascular mortality: the Osteoporotic Fractures in Men (MrOS) Study
Julie R Dominguez,Bryan Kestenbaum,Michel Chonchol,Geoffrey Block,Gail A Laughlin,Cora E Lewis,Ronit Katz,Elizabeth Barrett-Connor,Steve Cummings,Eric S Orwoll,Joachim H Ix,Osteoporotic Fractures in Men (MrOS) Study Research Group,S R Cummings,M C Nevitt,D C Bauer,K L Stone,D M Black,P M Cawthon,R Fullman,R Benard,T Blackwell,J Diehl,S Ewing,C Fox,M Jaime-Chavez,E Kwan,S Litwack,L Y Lui,A Mills,L Palermo,J Schneider,R Scott,D Tanaka,C Yeung,E Orwoll,L Marshall,J Babich Blank,L Lambert,B Chan,D Neevel,J Mougey,L Press,C E Lewis,J Shikany,P Johnson,E Clavino,C Oden,N Webb,K Hardy,S Felder,P Grayson,J Wilkoff,J King,T Johnsey,J Thompson,K Ensrud,H Fink,D King,N Michaels,N Nelson,C Bird,D Blanks,F Imker-Witte,K Moen,M Paudel,M Slindee,M Stefanick,A Hoffman,E Moore,K Kent,B Malig,S Wong,J Cauley,J Zmuda,M Danielson,L Harper,L Buck,M Nasim,D Cusick,D Moore,M Gorecki,D Lee,N Watson,C Bashada,C Newman,G Engleka,E Barrett-Connor,T Dam,M L Carrion-Petersen,P Miller,N Kamantigue,S Szerdi,G Reno
DOI: https://doi.org/10.1053/j.ajkd.2012.11.033
Abstract:Background: Serum phosphorus is associated with cardiovascular disease (CVD) in the general population, but may not comprehensively reflect phosphorus homeostasis. Whether urine phosphorus-creatinine ratio (a marker of intestinal absorption) or urine fractional excretion of phosphorus (FEPi; a marker of urinary phosphorus handling) is associated with risk of mortality or CVD is uncertain. Study design: Prospective observational study. Setting & participants: 1,325 community-dwelling men 65 years or older participating in the MrOS Study. Predictor: Serum phosphorus, urine phosphorus-creatinine ratio, and FEPi. Outcomes: All-cause and CVD death. Results: Mean age was 74 ± 6 (SD) years, estimated glomerular filtration rate was 75 ± 16 mL/min/1.73 m(2), and serum phosphorus level was 3.2 ± 0.4 mg/dL. During a median follow-up of 9.3 years, there were 364 (120 CVD) deaths. After adjustment for demographics, CVD risk factors, and kidney function, the risks of all-cause death in the highest quartiles of serum phosphorus (≥3.6 mg/dL), urine phosphorus-creatinine ratio (≥0.55), and FEPi (≥18%) were 1.63 (95% CI, 1.23-2.17), 1.22 (95% CI, 0.90-1.65), and 0.88 (95% CI, 0.64-1.23), respectively, compared to the lowest quartiles of each. Results were similar for CVD death. Results also were similar in those with estimated glomerular filtration rate ≥60 and <60 mL/min/1.73 m(2). Limitations: Older all-male cohort. Few had advanced chronic kidney disease. Spot urine specimens were used. Conclusions: In community-living older men, higher serum phosphorus concentrations are associated with all-cause and CVD death. In contrast, urine phosphorus-creatinine ratio and FEPi are not. These findings do not support using urine phosphorus-creatinine ratio or FEPi as adjuvant measures to predict risk of mortality or CVD in the general population.